Abstract
Nonalcoholic steatohepatitis (NASH) is a serious and rapidly growing problem affecting a population that was not previously recognized as high risk. Although treatments are limited, shedding light on those with a predisposition may allow for primary prevention, as there is presently no cure other than liver transplant. This study examines the risk factors, genetic predisposition, pathophysiology, and treatment options.